Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives

Katya Chobotova, Ann B. Vernallis, Fadzilah A.A. Majid

Research output: Contribution to journalArticle

Abstract

The medicinal qualities of pineapple are recognized in many traditions in South America, China and Southeast Asia. These qualities are attributed to bromelain, a 95%-mixture of proteases. Medicinal qualities of bromelain include anti-inflammatory, anti-thrombotic, fibrinolytic and anti-cancer functions. Existing evidence derived from clinical observations as well as from mouse- and cell-based models suggests that bromelain acts systemically, affecting multiple cellular and molecular targets. In recent years, studies have shown that bromelain has the capacity to modulate key pathways that support malignancy. It is now possible to suggest that the anti-cancer activity of bromelain consists in the direct impact on cancer cells and their micro-environment, as well as in the modulation of immune, inflammatory and haemostatic systems. This review will summarize existing data relevant to bromelain's anti-cancer activity and will suggest mechanisms which account for bromelain's effect, in the light of research involving non-cancer models. The review will also identify specific new research questions that will need to be addressed in order for a full assessment of bromelain-based anti-cancer therapy.
Original languageEnglish
Pages (from-to)148-156
Number of pages9
JournalCancer Letters
Volume290
Issue number2
Early online date22 Aug 2009
DOIs
Publication statusPublished - 28 Apr 2010

Fingerprint

Bromelains
Neoplasms
Ananas
Southeastern Asia
South America
Hemostatics
Research
China
Peptide Hydrolases
Anti-Inflammatory Agents

Keywords

  • animals
  • antineoplastic agents
  • bromelains
  • humans
  • neoplasms
  • signal transduction

Cite this

Chobotova, Katya ; Vernallis, Ann B. ; Majid, Fadzilah A.A. / Bromelain's activity and potential as an anti-cancer agent : Current evidence and perspectives. In: Cancer Letters. 2010 ; Vol. 290, No. 2. pp. 148-156.
@article{a652c7831ad941609e2ae09dbf3080d5,
title = "Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives",
abstract = "The medicinal qualities of pineapple are recognized in many traditions in South America, China and Southeast Asia. These qualities are attributed to bromelain, a 95{\%}-mixture of proteases. Medicinal qualities of bromelain include anti-inflammatory, anti-thrombotic, fibrinolytic and anti-cancer functions. Existing evidence derived from clinical observations as well as from mouse- and cell-based models suggests that bromelain acts systemically, affecting multiple cellular and molecular targets. In recent years, studies have shown that bromelain has the capacity to modulate key pathways that support malignancy. It is now possible to suggest that the anti-cancer activity of bromelain consists in the direct impact on cancer cells and their micro-environment, as well as in the modulation of immune, inflammatory and haemostatic systems. This review will summarize existing data relevant to bromelain's anti-cancer activity and will suggest mechanisms which account for bromelain's effect, in the light of research involving non-cancer models. The review will also identify specific new research questions that will need to be addressed in order for a full assessment of bromelain-based anti-cancer therapy.",
keywords = "animals, antineoplastic agents, bromelains, humans, neoplasms, signal transduction",
author = "Katya Chobotova and Vernallis, {Ann B.} and Majid, {Fadzilah A.A.}",
note = "2009 Elsevier Ireland Ltd. All rights reserved.",
year = "2010",
month = "4",
day = "28",
doi = "10.1016/j.canlet.2009.08.001",
language = "English",
volume = "290",
pages = "148--156",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier",
number = "2",

}

Bromelain's activity and potential as an anti-cancer agent : Current evidence and perspectives. / Chobotova, Katya; Vernallis, Ann B.; Majid, Fadzilah A.A.

In: Cancer Letters, Vol. 290, No. 2, 28.04.2010, p. 148-156.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bromelain's activity and potential as an anti-cancer agent

T2 - Current evidence and perspectives

AU - Chobotova, Katya

AU - Vernallis, Ann B.

AU - Majid, Fadzilah A.A.

N1 - 2009 Elsevier Ireland Ltd. All rights reserved.

PY - 2010/4/28

Y1 - 2010/4/28

N2 - The medicinal qualities of pineapple are recognized in many traditions in South America, China and Southeast Asia. These qualities are attributed to bromelain, a 95%-mixture of proteases. Medicinal qualities of bromelain include anti-inflammatory, anti-thrombotic, fibrinolytic and anti-cancer functions. Existing evidence derived from clinical observations as well as from mouse- and cell-based models suggests that bromelain acts systemically, affecting multiple cellular and molecular targets. In recent years, studies have shown that bromelain has the capacity to modulate key pathways that support malignancy. It is now possible to suggest that the anti-cancer activity of bromelain consists in the direct impact on cancer cells and their micro-environment, as well as in the modulation of immune, inflammatory and haemostatic systems. This review will summarize existing data relevant to bromelain's anti-cancer activity and will suggest mechanisms which account for bromelain's effect, in the light of research involving non-cancer models. The review will also identify specific new research questions that will need to be addressed in order for a full assessment of bromelain-based anti-cancer therapy.

AB - The medicinal qualities of pineapple are recognized in many traditions in South America, China and Southeast Asia. These qualities are attributed to bromelain, a 95%-mixture of proteases. Medicinal qualities of bromelain include anti-inflammatory, anti-thrombotic, fibrinolytic and anti-cancer functions. Existing evidence derived from clinical observations as well as from mouse- and cell-based models suggests that bromelain acts systemically, affecting multiple cellular and molecular targets. In recent years, studies have shown that bromelain has the capacity to modulate key pathways that support malignancy. It is now possible to suggest that the anti-cancer activity of bromelain consists in the direct impact on cancer cells and their micro-environment, as well as in the modulation of immune, inflammatory and haemostatic systems. This review will summarize existing data relevant to bromelain's anti-cancer activity and will suggest mechanisms which account for bromelain's effect, in the light of research involving non-cancer models. The review will also identify specific new research questions that will need to be addressed in order for a full assessment of bromelain-based anti-cancer therapy.

KW - animals

KW - antineoplastic agents

KW - bromelains

KW - humans

KW - neoplasms

KW - signal transduction

UR - http://www.scopus.com/inward/record.url?scp=77649180336&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2009.08.001

DO - 10.1016/j.canlet.2009.08.001

M3 - Article

C2 - 19700238

VL - 290

SP - 148

EP - 156

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -